Andrew Cheng Selected Research

Andrew Cheng Research Topics

Disease

12	Infections 01/2020 - 09/2003
4	Fibrosis (Cirrhosis) 03/2024 - 01/2021
3	Chronic Obstructive Pulmonary Disease (COPD) 01/2024 - 12/2016
3	Traumatic Brain Injuries (Traumatic Brain Injury) 05/2022 - 07/2008
2	Type 2 Diabetes Mellitus (MODY) 03/2024 - 01/2020
2	Obesity 03/2024 - 06/2008
2	Heart Failure 01/2024 - 11/2023
2	Inflammation (Inflammations) 12/2023 - 11/2016
2	Pulmonary Embolism 07/2021 - 07/2021
2	Nausea 10/2020 - 11/2017
2	COVID-19 05/2020 - 01/2020
2	Chronic Hepatitis B 11/2017 - 11/2016
2	Hepatitis B 11/2017 - 11/2016
2	Proteinuria 02/2017 - 08/2015
2	Osteoporosis 08/2014 - 03/2007
2	HIV Infections (HIV Infection) 04/2014 - 04/2005
1	Weight Loss (Weight Reduction) 03/2024
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2024
1	Death (Near-Death Experience) 01/2024
1	Non-alcoholic Fatty Liver Disease 12/2023
1	Human Influenza (Influenza) 11/2023
1	Brain Ischemia (Cerebral Ischemia) 05/2022
1	Craniocerebral Trauma (Head Injury) 05/2022
1	Alcoholic Fatty Liver 01/2021
1	Vomiting 10/2020
1	Chronic Disease (Chronic Diseases) 06/2019
1	Chronic Kidney Failure (Chronic Renal Failure) 12/2018
1	Chronic Renal Insufficiency 12/2018
1	Myocardial Infarction 01/2018
1	Neutropenia 01/2018
1	Headache (Headaches) 01/2018
1	Renal Colic 01/2018
1	Hepatitis C 11/2017
1	Coinfection 11/2017
1	Albuminuria 02/2017
1	Urticaria (Hives) 01/2017
1	Fatigue 12/2016
1	Constrictive Pericarditis 11/2016
1	Mitral Valve Insufficiency (Mitral Regurgitation) 11/2016
1	Hemorrhage 08/2016
1	Hypertension (High Blood Pressure) 04/2016
1	Osteonecrosis (Kienbock's Disease) 08/2014
1	Breast Neoplasms (Breast Cancer) 06/2014

Drug/Important Bio-Agent (IBA)

12	Emtricitabine (Emtriva)FDA Link 12/2018 - 04/2014
12	tenofovir alafenamideIBA 12/2018 - 08/2015
9	Tenofovir (Viread)FDA Link 11/2017 - 09/2003
5	TabletsIBA 12/2018 - 04/2014
5	elvitegravirIBA 12/2018 - 08/2015
5	bictegravirIBA 01/2018 - 01/2017
4	CobicistatIBA 12/2018 - 11/2016
4	dolutegravirIBA 01/2018 - 01/2017
4	emtricitabine tenofovir alafenamideIBA 02/2017 - 11/2016
3	Glucose (Dextrose)FDA LinkGeneric 03/2024 - 01/2020
3	Proteins (Proteins, Gene)FDA Link 05/2020 - 06/2014
3	CreatinineIBA 12/2018 - 04/2016
3	Lamivudine (Epivir)FDA Link 01/2018 - 11/2017
3	abacavir (Ziagen)FDA Link 01/2018 - 11/2017
3	Rilpivirine (TMC-278)IBA 01/2017 - 04/2014
2	Neutralizing AntibodiesIBA 05/2020 - 01/2020
2	Protease Inhibitors (Protease Inhibitor)IBA 01/2018 - 08/2015
2	RNA (Ribonucleic Acid)IBA 11/2017 - 11/2017
2	Diphosphonates (Bisphosphonates)IBA 08/2014 - 03/2007
1	semaglutideIBA 03/2024
1	dulaglutideIBA 03/2024
1	Glucagon-Like Peptide-1 ReceptorIBA 03/2024
1	Liraglutide FDA Link 03/2024
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 03/2024
1	nasIBA 12/2023
1	VaccinesIBA 11/2023
1	Influenza Vaccines (Influenza Vaccine)FDA Link 11/2023
1	Complement C3 (C3 Complement)IBA 01/2023
1	Oxygen (Dioxygen)IBA 05/2022
1	fibroblast growth factor 21IBA 01/2021
1	Butyrates (Butyrate)IBA 01/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020
1	Insulin (Novolin)FDA Link 01/2020
1	LipidsIBA 01/2018
1	HLA-B Antigens (HLA-B)IBA 11/2017
1	RacivirIBA 01/2017
1	efavirenz (Sustiva)FDA Link 01/2017
1	prednylidene (Pred)IBA 12/2016
1	Biomarkers (Surrogate Marker)IBA 11/2016
1	fibrin fragment D (D-dimer)IBA 11/2016
1	Lipopolysaccharide ReceptorsIBA 11/2016
1	C-Reactive ProteinIBA 11/2016
1	AnticoagulantsIBA 08/2016
1	Warfarin (Coumadin)FDA LinkGeneric 08/2016
1	ProdrugsIBA 08/2015
1	AnionsIBA 06/2014
1	Peptides (Polypeptides)IBA 06/2014
1	CalreticulinIBA 07/2010
1	EpitopesIBA 07/2010

Therapy/Procedure

10	Therapeutics 03/2024 - 07/2008
3	Physical Therapy Modalities (Physical Therapy Technique) 10/2020 - 07/2008
1	Palliative Care (Palliative Therapy) 01/2024
1	Critical Care (Surgical Intensive Care) 05/2022
1	Subcutaneous Injections 01/2021
1	Pericardiectomy 11/2016
1	Art Therapy 11/2016
1	Induced Hyperthermia (Thermotherapy) 08/2014